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Abstract
Purpose: The objective of this study was to investigate the effects of chronic Rhodiola rosea (R. rosea) supplementation on mental and physical
performance, as well as hormonal and oxidative stress biomarkers.
Methods: Healthy male students received either R. rosea extract (600 mg/day; RR) or placebo (PL) in a randomized double-blind trial. Prior to
supplementation (term I) and following 4 weeks of supplementation (term II), the students underwent psychomotor tests for simple and choice
reaction time, included in the Vienna Test System. Also, the subjects performed VO2peak test. Blood samples were obtained before and after the test
to measure the hormonal profile (cortisol, testosterone, and growth hormone), as well as the biomarkers of oxidative stress (lipid hydroperoxides,
total antioxidant capacity, and superoxide dismutase) and muscle damage (creatine kinase).
Results: R. rosea ingestion shortened reaction time and total response time. Moreover, a greater relative increase in the number of correct
responses was observed in RR group as compared to the PL group. No changes in endurance exercise capacity and hormonal profile were observed
after R. rosea ingestion. R. rosea ingestion raised plasma total antioxidant capacity. It did not, however, affect other measured parameters.
Conclusion: Chronic R. rosea ingestion does not affect physical performance, but can improve the results of some psychomotor tests (simple and
choice reaction time) in young, healthy, and physically active men. The improvements in mental performance, however, at least in our study, seem
not to be related to changes in cortisol release or antioxidant activity of R. rosea extract. Thus, the specific mechanisms responsible for these effects
still need to be elucidated.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Rhodiola rosea (R. rosea) is the plant with roots containing
biologically active substances including flavonoids and pheno-
lic glycosides: salidrosides and rosavins.1 These substances
allow an organism to counteract adverse physical, chemical,
or biological stressors by generating non-specific resistance.
Due to these compounds R. rosea has been purported to possess
anti-fatigue and ergogenic properties,2 which may be reflected
in an enhancement of work capacity.3 Nonetheless, no
improvements in exercise performance parameters were
observed in humans after chronic R. rosea ingestion.4–6
Various studies involving young healthy human subjects
have shown that chronic R. rosea supplementation can diminish
mental fatigue as indicated by the improvement in the results
of tests involving complex perceptive and cognitive cerebral
functions,7 as well as neuro-motoric function.8 Conversely,
another study9 reported no changes in mental performance
after R. rosea intake; however, the dose of R. rosea extract was
similar to that previously described.7,8
It has been demonstrated that beneficial stress-protective
activity of Rhodiola may be associated with the hypothalamic–
pituitary–adrenal axis and regulation of key mediators of stress
response including cortisol.10 However, no studies investigated
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the effects of chronic R. rosea supplementation on cortisol
release in healthy physically active people.
The mechanism by which R. rosea may exert its ergogenic
effects is free radical mitigation.2 It is well known that strenu-
ous exercise increases free radical production in skeletal
muscles which may contribute to fatigue by decreasing calcium
sensitivity of the myofilaments and depressing force.11 It has
been also suggested that some antioxidants can inhibit oxidative
stress and delay muscle fatigue.11 Antioxidant potential of
R. rosea has been shown during in vitro studies.12,13 Four major
bioactive substances (salidroside, rosin, rosavin, and rosarin)
from R. rosea have been shown to scavenge the reactive oxygen
species (ROS) in dose-dependent manner.14 Moreover, alterna-
tive to free radical scavenging, the activation of enzymatic
system by signal transduction pathway and protection against
oxidative damage has been recently proposed as a major
mechanism of action for plant antioxidants.15 In a study of
Huang et al.,14 a 4-week treatment with R. rosea extract
increased protein expression of antioxidant enzymes in rat
liver. Moreover, rats treated with R. rosea had a significantly
attenuated exercise-induced oxidative stress in blood, liver,
and skeletal muscle, with concurrent enhanced swimming
performance.14 Unfortunately, these observations were not con-
firmed in trained athletes.16 Similarly, 2 studies6,17 reported an
attenuation in exercise-induced increase in plasma creatine
kinase (CK) activity as a result of R. rosea supplementation,
whereas no effect of R. rosea on this parameter was observed in
other studies.16,18
Altogether, above cited studies on R. rosea’s effects are
ambiguous that may partially result from the dose of R. rosea
extract. In fact, compared to animal studies, in the majority of
human studies on chronic R. rosea supplementation the dose of
the extract was relatively low, amounting to 100–200 mg,6–9,16
while higher doses (≥600 mg) were administered for only 4–7
days, and followed by a lower dose.4,5 Only in 2 studies17,18 a
higher dose for longer time of supplementation (600 mg for
30 days) was used; however, the only biochemical parameters
measured were muscle damage and inflammatory markers.
Moreover, no studies were performed thus far, analyzing simul-
taneously the effects of supplementation on mental perfor-
mance, work capacity, hormonal profile, and oxidative stress
biomarkers. Therefore, the aim of the present study was to
investigate the effects of chronic R. rosea supplementation
(600 mg daily for 4 weeks) on select parameters of mental
performance, physical capacity, hormonal profile, exercise-
induced oxidative stress, and muscle damage biomarkers in
healthy physically active male students during the examination
period.
2. Methods
2.1. Subjects and supplementation
Twenty-six male physical education students were enrolled
in the study. All the students were healthy non-smokers without
recent infections or joint or bone injuries; they were not
engaged in high-performance sports and did not drink alcohol
on a regular basis. The students did not ingest any supplements
for at least 2 months prior to the study. Screening for the above
mentioned criteria was accomplished via a special question-
naire filled out during subject recruitment.
The study was designed in agreement with the Declaration
of Helsinki. Students volunteered to the study and gave their
informed consent. Potential risks and discomforts were
explained to each student. The protocol of the study was
approved by the Bioethical Committee at the Academy of
Physical Education in Warsaw.
The recruited students (n = 26) were randomly assigned to 1
of 2 experimental groups. Using the double-blind approach, the
treatment group ingested 600 mg of R. rosea extract per day
(3 tablets per day in 3 divided doses, 1 tablet contained 200 mg
of the extract) for a 4-week period (RR group; n = 13). At the
same time, the control group ingested 3 placebo tablets per day
(PL group, n = 13). All subjects and investigators (apart from 1
individual not directly involved in the data collection) were
blind to treatment group allocation and remained blinded until
data analysis. The compliance was measured by tablet counting.
The participants who returned no more than 15% of their tablet
dose were classified as “compliant”.
Commercially available R. rosea extract was standardized to
3% rosavins (analyzed by high performance liquid chromatog-
raphy; Rhodiola, Naturell, Sweden). Total content of phenolic
compounds in water and ethanol solution of R. rosea tablets
was determined by the Folin–Ciocalteu method as previously
described19 and was expressed in milligram equivalents of
gallic acid per tablet. The content of salidroside in R. rosea
tablet was estimated spectrophotometrically according to the
method described previously.20 Placebo tablets, manufactured
by Celon Pharma (Łomianki, Poland), contained maltodextrin,
microcrystalline cellulose, magnesium stearate, and caramel
(coloring) and appeared identical to the tablets of R. rosea
extract.
2.2. Psychomotor tests
The study flowchart is displayed in Fig. 1. Prior to the
experiment, and after 4-week supplementation with RR or PL,
students performed tests assessing their reaction times: simple
and choice reaction time, included in the Vienna Test System.21
Tests were carried out in the morning the day before the incre-
mental exercises were performed, following an overnight fast.
2.2.1. Simple reaction
An examined individual was seated in front of a monitor
with the index finger of dominant hand placed on a sensor
(so-called “stand-by key”) located on the control panel. The
student was instructed to maintain finger on the “stand-by key”,
and move it to the “reaction key” as soon as the stimulus
(yellow light) appeared.
The tested parameters are: A1—median of reaction time
(interval between the beginning of a given stimulus and the
release of the “stand-by key”, in ms); A2—median of move-
ment time (interval between the release of the “stand-by key”
and pressing the “reaction key”, in ms); A3—median of total
response time (interval between the beginning of a given
stimulus and pressing the “reaction key”, in ms). Reliability
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coefficient was r = 0.90 and r = 0.95 for A1 and A2,
respectively.
2.2.2. Choice reaction
An examined individual was instructed to respond appropri-
ately and as soon as possible to the stimuli appearing on the
screen using upper and lower limbs. Five colored (white,
yellow, blue, green, and red), circle-shaped optical stimuli
appeared on the screen. Each circle appearing on the monitor
was assigned its own “reaction key” on the control panel that
corresponded to the color of the stimulus. The examined indi-
vidual was asked to respond to the stimulus by pressing the
matching “reaction key” with right or left hand. Additionally,
the subject was instructed to use the foot to press the right or left
pedal whenever a white rectangular light appeared on the black
background of the screen. Finally, the test included reaction to
acoustic stimuli. The participant was instructed to press either a
gray or a black rectangular button as soon as possible after
hearing high or low sound, respectively.
The tested parameters are: B1—number of correct responses
(n); B2—number of incorrect and missed responses (n);
B3—median of response time (s). Reliability coefficient was
r = 0.99 for all 3 above mentioned variables.
2.3. Exercise protocol
Each student performed 2 incremental cycle ergometer
tests to volitional fatigue on 2 separate occasions: before
(term I) and after 4 weeks of supplementation (term II). The
students were asked not to perform any strenuous exercise 3
days before testing. The tests were conducted on cycle ergom-
eter (Ergomedic 839E; Monark, Vansbro, Sweden). The tests
were performed in the morning following 12 h overnight fast, at
air temperature between 19°C and 21°C and with 40%–60%
relative humidity. Each subject was tested at the same time of
day at the baseline (term I) and the endpoint (term II) to control
the influence of circadian and diurnal rhythms. Throughout
the test, pedal frequency was fixed at 60 rpm. Initial workload
was set at 1 W/kg, after which workload was increased by
0.75 W/kg every 3 min until volitional exhaustion, with 1-min
rest periods between 3-min exercises. Capillary blood samples
were drawn before the test, during each 1-min rest period and
3 min after the test. During the test, oxygen uptake was con-
tinuously measured using breath-by-breath ergospirometry
system START 2000 (MES, Cracow, Poland), which was cali-
brated prior to each experiment using gas mixtures of known
composition. During the test, heart rate (HR) was continuously
registered (Polar, Finland). The test was discontinued, and time
to exhaustion (TTE) and VO2peak were recorded, when any 2 of
the maximal criteria occurred as previously described.22 Addi-
tionally, power and HR at the 4 mmol/L lactate threshold (PLT
and HRLT, respectively) were evaluated.
2.4. Blood samples
Blood samples were drawn from a fingertip and ulnar vein (into
tubes containing heparin), before the exercise test (rest), 3 min
after the test (post), and following 24-h recovery period (24-h).
Plasma was obtained by centrifugation at 3000 rpm for 10 min at
4°C. Erythrocyte fraction was resuspended and washed 3 times
with cold isotonic saline solution. Plasma and washed erythro-
cytes were frozen and stored at −70°C until analysis.
2.5. Biochemical analyses
Capillary blood was assayed for the concentration of lactate
(LA) with a ready diagnostic cuvette kit (Dr. Lange, catalogue
No. LKM 140, Dormitz, Germany) and Miniphotometer Plus
LP 20 (Hach Lange, Dormitz, Germany) as well as for hemo-
globin concentration and hematocrit—with the use of an auto-
mated analyzer (OMNI-C analyzer, Roche Diagnostics, Vienna,
Austria).
Activity of superoxide dismutase (SOD) was determined for
erythrocytes (expressed in U/gHb), whereas blood plasma was
analyzed for: activity of CK, concentration of lipid hydroper-
oxides (LHs) and total antioxidant capacity (TAC), and concen-
trations of testosterone (T), cortisol (C), and growth hormone
(GH). Activity of CK was assayed with the use of Alpha
Fig. 1. Study flowchart. Rest: pre-exercise blood sampling; post: 3 min post-exercise blood sampling; recovery: 24-h recovery blood sampling.
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Diagnostics kit (Alpha Diagnostic Int., San Antonio, TX, USA).
Plasma LHs were determined colorimetrically using a commer-
cial kit (OXIS Internatl., Portland, OR, USA), whereas Randox
diagnostic kits (Randox, Crumlin, UK) were used to measure
TAC and SOD. To determine T, C, and GH levels, we used
immunoenzymatic methods based on the ready-to-use sets by
ELISA (IBL, International GmbH, Hamburg, Germany) and
hGH-EASIA BIOSOURCE (Biosource Diagnostics, Solingen,
Germany). All post-exercise samples were corrected for plasma
volume shift according to the method of Dill and Costill.23
2.6. Statistical analysis
Statistical analysis was performed using R Statistical
Software.24 All data are presented as mean ± SD. Normally-
distributed parameters (age, height, body mass, etc.) were com-
pared using the unpaired t tests. In the case of other not
normally distributed variables (based on the results of the
Shapiro–Wilk test and visual inspection—quartile distribution
plots, confirmed by Bartlett’s test), we used non-parametric
tests for comparative analysis. The data within each group were
analyzed by Wilcoxon test, and Mann–Whitney test was used to
compare mean values between 2 groups. The accepted level of
significance was defined as p < 0.05.
3. Results
The anthropometric characteristics of participants in the 2
groups were similar (age 20.9 ± 0.2 and 20.5 ± 0.3 years, height
184.7 ± 2.1 and 182.1 ± 2.2 cm, body mass 81.1 ± 3.0 and
79.1 ± 2.8 kg; for PL and RR groups, respectively).
The total content of phenolic compounds in ethanol solution
of R. rosea tablet was 47 mg/tablet, whereas in the case of water
solution it was 25 mg/tablet (as determined by the Folin–
Ciocalteu method19). The content of salidroside in R. rosea
tablet was found to average 4.7 mg of salidroside per tablet
(1.1% of tablet weight on average). Taking into account that 1
tablet contained 200 mg of R. rosea extract, salidroside content
was 2.35% of dry weight of the extract. The percentage of
compliant was 100% for both RR and PL groups.
3.1. Psychomotor tests
The results of simple reaction (A1–3) and choice reaction
(B1–3) testing are summarized in Table 1 and in Fig. 2.
Either prior to the experiment (term I) or after its completion
(term II), no significant differences were observed between PL
and RR groups in analyzed parameters of simple and choice
reaction (Table 1). However, significant differences within the
RR group were noted in the case of 3 parameters (A1, A3,
and B1), when relative changes of studied characteristics (i.e.,
between terms I and II) were considered (Fig. 2).
In both PL and RR groups, no significant changes in A2 were
noted in term II (Table 1). However, a significant improvement
in A1 (shortening by 21.3 ms; 9.5%; p < 0.05) was observed in
RR group, in contrast to nonsignificant change noted in PL
group (Table 1). Relative change in A1 observed in RR group
differed significantly (p < 0.05) from that detected in PL group
(Fig. 2A). Similarly, the relative change in A3 significantly
improved (shortening by 5.7%; p < 0.05) in RR group as com-
pared to change observed in PL group (Fig. 2A).
Table 1
Psychomotor performance and exercise parameters determined before (term I) and after (term II) 4-week supplementation with PL or RR (mean ± SD).
Variable PL (n = 13) RR (n = 13)
Term I Term II Term I Term II
Psychomotor performance
Simple reaction
Reaction time (A1; ms) 240.4 ± 9.7 253.5 ± 11.4 247.8 ± 12.8 226.5 ± 8.3*
Movement time (A2; ms) 97.3 ± 5.6 99.0 ± 6.3 109.3 ± 4.1 112.5 ± 7.8
Total response time (A3; ms) 337.6 ± 10.9 352.5 ± 15.1 357.1 ± 14.1 339.0 ± 13.3
Choice reaction
Number of correct responses (B1; n) 251.3 ± 9.8 267.9 ± 9.5* 232.5 ± 5.8 269.6 ± 9.5**
Number of incorrect responses (B2; n) 43.9 ± 6.9 44.8 ± 6.1 59.2 ± 5.6 50.8 ± 4.0
Response time (B3; s) 0.708 ± 0.015 0.661 ± 0.011** 0.712 ± 0.011 0.666 ± 0.016**
Exercise capacity
LArest (mmol/L) 1.45 ± 0.05 1.49 ± 0.09 1.44 ± 0.08 1.23 ± 0.07*,#
LAmax (mmol/L) 14.25 ± 1.25 15.47 ± 1.24 14.25 ± 1.13 13.29 ± 0.89
HRrest (beats/min) 70 ± 4 72 ± 2 69 ± 2 68 ± 4
HRmax (beats/min) 190 ± 2 190 ± 3 183 ± 3 184 ± 3
HRLT (beats/min) 151 ± 4 147 ± 3 150 ± 4 144 ± 3
Pmax (W) 303.5 ± 15.9 290.5 ± 15.9* 293.6 ± 13.5 307.5 ± 12.1
PLT (W) 165.6 ± 6.7 170.5 ± 6.5 172.0 ± 6.7 176.2 ± 6.2
VO2peak (mL/kg/min) 48.19 ± 1.97 47.33 ± 1.66 50.76 ± 1.95 49.37 ± 1.90
TTE (s) 789.1 ± 18.2 779.0 ± 22.8 800.0 ± 19.5 820.8 ± 28.0
* p < 0.05, **p < 0.01, compared to Term I (within group), Wilcoxon test.
# p < 0.05, compared with Term II in PL group, Mann-Whitney test.
Abbreviations: HRrest = heart rate at rest; HRmax = maximal heart rate; HRLT = heart rate at lactate threshold; LArest = blood lactate concentration at rest;
LAmax = blood lactate concentration after an incremental cycloergometer test; Pmax = maximal power; PLT = power at lactate threshold; PL = placebo; RR = rhodiola
rosea; TTE = time to exhaustion; VO2peak = peak oxygen volume consumption.
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In both groups, significant improvements in B1 and B3 were
observed in parameters of choice reaction (Table 1), while no
significant change was noted in B2. Noticeably, a relative
increase in B1 was significantly higher in RR group (nearly
10%, p < 0.05) than in PL group (Fig. 2B). No significant
differences were observed between PL and RR groups (Fig. 2B)
with respect to B2 and B3.
3.2. Exercise parameters
Comparative analysis of the performance parameters
between terms I and II of the study in the PL and RR groups
was compiled in Table 1. Significant decrease in peak power
(Pmax) was observed in PL group in term II as compared to term
I (p < 0.05). On the contrary, in RR group, Pmax did not change
significantly throughout the experimental period (p > 0.05).
Although absolute values of Pmax did not differ between PL and
RR, slight but significant differences in relative changes in Pmax
were observed between PL and RR groups (−4.1% vs. 5.7%,
respectively; p < 0.05). Moreover, 4 weeks of R. rosea ingestion
caused a significant decrease in resting LA concentration in
blood in RR group (p < 0.05). Apart from changes in Pmax and
LArest, the other parameters (VO2peak, TTE, PLT, and LAmax, as
well as HR values) did not change significantly in both groups.
3.3. Redox state, muscle damage, and hormonal profile
Table 2 shows the values of oxidative stress and muscle
damage biomarkers. In RR group, resting plasma TAC
increased significantly in term II as compared to term I (by
22%; p < 0.05), whereas no signifiance changes were observed
in PL group. In case of other parameters (SOD, LHs, CK), no
significant differences between Terms I and II were observed
neither in each group, nor between PL and RR groups.
In term I, in both groups, plasma TAC increased post-
exercise (p < 0.05) and subsequently decreased slightly after
24-h of recovery (p < 0.05). In term II, plasma TAC did not
change significantly in both groups. Incremental exercise
caused significant increase in SOD activity in PL, but only in
term I. In RR group, no significant changes in SOD activity
were observed in either term. In both terms, plasma LH con-
centrations increased significantly immediately after exercise
(p < 0.05), but remained unchanged during recovery in both
groups. Plasma CK activity increased post-exercise in both
groups, but remained unchanged during recovery in term I
(p < 0.05). There were no significant changes in CK activity
after the incremental exercise in term II.
No significant changes in hormonal response (Table 2)
betweenTerms I and II were observed in either PL and RR group.
Moreover, all hormonal parameters analyzed were unaffected by
R. rosea intake when compared to the placebo treatment.
4. Discussion
It has been suggested that R. rosea can exert stress resistant
properties. In the present study, the last week of the experiment
corresponded to the period of the examination session for all
participating students. Under such circumstances, a 4-week
supplementation with R. rosea was reflected in improved
results of psychomotor tests. In the simple reaction testing,
R. rosea ingestion resulted in significantly shorter reaction
time, with resultant improvement of total reaction time,
although it did not affect movement time. Surprisingly, in the
case of choice reaction ability testing, significant improvement
in the number of correct responses and response time was
documented in both studied groups. This phenomenon can be
interpreted as a “learning effect” (i.e., practicing the technique
and formulating a strategy for testing procedure). Although the
students in our study were given precise instructions about
testing procedures prior to the first evaluation (in term I), a
possible limitation of this study is the lack of a planned pretest
before the first evaluation. On the other hand, previous study25
showed no learning effects on reaction time test as measured by
the Vienna Test System. Moreover, it must be added, that in the
case of the number of correct responses in our study, a signifi-
cantly greater increase was observed in RR as compared to PL
(16.0% vs. 6.8%; p < 0.05). Moreover, the improvement in
number of incorrect responses was seen in RR, but not in PL,
however, these differences were not significant, maybe because
of higher SD.
Similar to our results, other investigations have produced
mixed results. Spasov et al.8 investigated the effect of R. rosea
supplementation (100 mg daily for 20 days) on mental
Fig. 2. Relative (%) change (mean ± SD) in the simple (A) and choice (B)
reaction parameters evaluated by the Vienna Test System, after 4-week
supplementation with placebo (PL) or Rhodiola rosea (RR). *p < 0.05,
compared with PL group, Mann–Whitney test. A1 = reaction time;
A2 = movement reaction; A3 = total response time; B1 = number of correct
responses; B2 = number of incorrect responses; B3 = median of response time.
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performance in medical students. They observed a significant
improvement in mental fatigue (by self-assessment) and neuro-
motor test (accuracy of movement vs. speed in maze test) com-
pared with the control groups, but the results of neuromuscular
tapping test or the correction of text tests were found to be
lacking significance. No effect of acute (200 mg once) and
4-week R. rosea intake (200 mg daily) on speed of limb move-
ment, reaction time, and ability to sustain attention was found in
the study by De Bock et al.9 in healthy students. Taking into
account inconclusive results of the above cited studies and our
results, the answer as to whether R. rosea ingestion improves
neural or cognitive performance is problematic. Differences in
results can be mediated by R. rosea dose and test specificity
since a wide variety of tests is used in the evaluations. It must
be emphasized that contrary to the above cited studies, we used
the Vienna Test System, a very reliable, recognized, and vali-
dated testing system,25,26 to evaluate mental performance in our
study. Thus, the finding from this investigation is that chronic
R. rosea ingestion can improve some parameters of mental per-
formance like reaction time and the number of correct
responses as evaluated by the Vienna Test System in young,
healthy, and physically active men.
So far, several mechanisms have been proposed to be
involved in improvement of the cognitive and/or neural
performance following R. rosea ingestion. Among others, the
results of animal studies indicate that the anti-fatigue effect of
Rhodiola species may be related to changes in cortisol
secretion,27 probably as a result of neuropeptide Y activation by
salidroside constituent.28 However, no changes in salivary cor-
tisol were observed after submaximal exercise as a result of
acute R. rosea intake in healthy individuals.29 Similarly, in our
study we did not observe any changes in plasma cortisol fol-
lowing chronic R. rosea ingestion. It must be emphasized,
however, that further study with more post-exercise time points
should be conducted to confirm these findings.
Some literature data indicate that R. rosea may stimulate the
synthesis, transport, and receptor activity of opioid receptors
and peptides such as β-endorphins.2 This mechanism may be
responsible for an improvement not only in cognitive perfor-
mance, but also in endurance exercise capacity, since endog-
enous opioid system is involved in the modulation of pain
tolerance.30 However, in our study no changes in TTE,
VO2peak, HR values, or anaerobic threshold were observed after
R. rosea supplementation. It cannot be excluded that enhanced
metabolization/degradation of R. rosea, administered chroni-
cally at a relatively high dose, might occur in our study; con-
sequently, the time elapsed between ingestion of the last dose of
R. rosea and the incremental exercise test (1.5–2 h) might be
too long to affect physical performance. On the other hand, De
Bock et al.9 observed an increase in TTE and VO2peak after acute
Table 2
Blood parameters of oxidative stress, muscle damage, and hormonal profile determined at rest (before incremental exercise), 3 min post-exercise, and following 24-h
recovery, before (term I) and after (term II) 4-week supplementation with PL or RR (mean ± SD).
Variable Time PL (n = 13) RR (n = 13)
Term I Term II Term I Term II
TAC (mmol/L) Rest 1.38 ± 0.06a 1.50 ± 0.04a 1.34 ± 0.06a 1.63 ± 0.06a,*
Post 1.54 ± 0.05b 1.62 ± 0.06a 1.46 ± 0.02b 1.54 ± 0.06a
24-h 1.48 ± 0.04a 1.50 ± 0.04a 1.40 ± 0.04a 1.63 ± 0.11a
SOD (U/gHb) Rest 1143.1 ± 60.9a 1000.4 ± 147.1a 1132.1 ± 91.1a 1007.5 ± 80.2a
Post 1395.4 ± 90.8b 1140.9 ± 79.9a 1225.0 ± 70.5a 1201.6 ± 98.4a
24-h 1231.8 ± 95.8a,b 988.9 ± 107.5a 1266.0 ± 90.5a 1217.9 ± 60.6a
LHs (μmol/L) Rest 2.48 ± 0.26a 2.36 ± 0.26a 2.42 ± 0.28a 2.46 ± 0.25a
Post 3.48 ± 0.38b 3.40 ± 0.41b 3.43 ± 0.48b 3.44 ± 0.34b
24-h 3.19 ± 0.56a,b 2.55 ± 0.29a,b 3.22 ± 0.62a,b 2.48 ± 0.35a,b
CK (U/L) Rest 141.4 ± 17.2a 122.6 ± 18.5a 118.8 ± 12.1a 110.0 ± 9.2a
Post 170.9 ± 18.8b 126.1 ± 19.6a 141.0 ± 16.1b 119.6 ± 11.0a
24-h 161.0 ± 22.1a,b 104.1 ± 9.2a 123.6 ± 9.3a,b 106.3 ± 10.4a
C (nmol/L) Rest 518.1 ± 25.2a 507.3 ± 25.2a 540.8 ± 19.3a 552.7 ± 25.4a
Post 376.1 ± 34.5b 390.6 ± 35.6b 429.5 ± 43.7b 376.4 ± 55.0b
24-h 480.0 ± 33.6a 530.0 ± 25.9a 484.6 ± 22.6a,b 524.2 ± 25.7a
T (ng/mL) Rest 24.7 ± 2.1a 26.5 ± 2.5a 21.7 ± 2.2a 21.6 ± 1.2a
Post 23.4 ± 2.3a 27.8 ± 2.5a 19.8 ± 1.9a 23.9 ± 1.7a
24-h 24.7 ± 2.2a 26.3 ± 2.8a 22.5 ± 2.1a 23.7 ± 1.3a
T/C ratio Rest 4.8 ± 0.5a 5.3 ± 0.5a 4.1 ± 0.5a 3.9 ± 0.2a
Post 6.7 ± 1.1a 7.7 ± 1.0b 5.6 ± 1.1a,b 6.7 ± 0.9b
24-h 5.3 ± 0.4a 5.1 ± 0.7a 4.7 ± 0.5b 4.6 ± 0.3c
GH (ng/mL) Rest 0.2 ± 0.1a 0.2 ± 0.1a 0.3 ± 0.1a 0.2 ± 0.1a
Post 13.7 ± 3.3b 12.7 ± 5.3b 14.5 ± 3.1b 12.4 ± 3.7b
24-h 0.3 ± 0.1a 0.2 ± 0.1a 0.2 ± 0.1a 0.3 ± 0.1a
a,b,c Values at rest, 3 min post-exercise, and after 24-h recovery (within the same group and at the same term) that do not have common letters are significantly
different, Wilcoxon test, p < 0.05.
* p < 0.05 compared with term I within group; Wilcoxon test.
Abbreviations: C = cortisol; CK = creatine kinase; GH = growth hormone; LHs = lipid hydroperoxides; PL = placebo; RR = rhodiola rosea; SOD = superoxide
dismutase; T = testosterone; TAC = total antioxidant capacity.
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(200 mg once) but not chronic R. rosea ingestion at low doses
(200 mg/day). Thus, R. rosea may exert a temporary effect that
is no longer observed upon repeated intake,9 irrespective of the
dose. It has been confirmed in a recent study of Noreen et al.,29
in which acute R. rosea ingestion decreased HR response to
submaximal exercise and improved endurance performance.
Although, in our investigation, R. rosea supplementation pre-
vented a decrease in Pmax and decreased the resting lactate
concentrations, these changes were too small to state about
anti-fatigue effect of R. rosea ingestion. Therefore, taking into
account our study and previous studies,6,18 it is unlikely that
chronic R. rosea ingestion may enhance physical performance.
It has been proposed that R. rosea may have antioxidant
properties.2 In our study, an increase in resting plasma TAC was
observed as a result of R. rosea supplementation. It can indi-
rectly reflect increased bioavailability of antioxidant com-
pounds from R. rosea extract since plasma levels of endogenous
antioxidants such as uric acid and albumin, which contribute
primarily to plasma TAC, were not affected by R. rosea supple-
mentation (data not shown). Although, in present study, the
exercise test induced oxidative stress and muscle damage, these
parameters were not affected by R. rosea ingestion. Our results
are in agreement with the study of Skarpanska-Stejnborn
et al.,16 in which much lower dose of R. rosea extract was used
as compared to our study (200 vs. 600 mg a day, respectively).
Similarly, no effects of R. rosea supplementation (600 mg/day)
on exercise-induced muscle damage and inflammatory markers
in plasma were observed in runners following a competitive
marathon.18 Finally, it is believed that salidroside and rosavins
are responsible for the effects of R. rosea ingestion. Recently,
several hypothetical mechanisms of R. rosea action have been
proposed. They include cell response regulation, at the tran-
scriptional level, affecting various signaling pathways associ-
ated with beneficial effects of R. rosea on different disorders.31
Interestingly, the biological activity of the R. rosea total extract
differed from the activity of the purified compounds (i.e.,
salidroside, triandrin, and tyrosol).31 Therefore, it cannot be
excluded that other compounds contained in the extract (includ-
ing flavonoids) may also affect brain function.
The potential of flavonoids to promote memory, learning, and
cognitive function has been described in a number of studies.32–34
Aside from antioxidant activity, flavonoids may influence brain
function in multiple ways, including interaction with important
neuronal signaling cascades controlling long-term potentiation
and memory.35 Taking into account low bioavailability of phe-
nolic antioxidants, their role in direct scavenging free radicals in
vivo has even been questioned. Instead, paradoxical oxidative
activation of Nrf2 (nuclear factor erythroid 2-related factor 2),
the transcription factor regulating expression of genes coding
phase II and some phase III enzymes (e.g., heme oxygenase-1),
so called para-hormesis or xeno-hormesis, has been recently
proposed to understanding of the physiological mechanism of
action for plant phenols.15 Other adaptive cellular response path-
ways in nerve cells may include those involving the transcription
factors like nuclear factor-kB (NF-kB), hypoxia-inducible
factor 1α (HIF-1α), peroxisome proliferator-activated receptors
(PPARs), and forkhead box subgroup O (FOXO), as well as the
production and action of trophic factors and hormones.36
These mechanisms of action may allow flavonoids to improve
not only age and neurodegenerative diseases-related decrease
in mental performance, but also enhancing “normal” mental
performance.37 Interestingly, flavonoids supplementation in
healthy students has been found to improve cognitive function
and test scores on university exams.38 Thus, in our study, despite
no influence of R. rosea supplementation on oxidative stress
parameters, it cannot be excluded that phenolic compounds of
R. rosea extract, including flavonoids, via influencing brain
function, may be responsible for improvements observed in
mental performance parameters. Thus, more studies are needed
to understand the exact mechanisms of action of R. rosea extract
in healthy population.
In conclusion, we found that chronic R. rosea ingestion can
improve some parameters of psychomotor performance in
young, healthy, and physically active men. However, these
effects seem not to be related to changes in cortisol release or
antioxidant activity of R. rosea extract. Thus, the exact mecha-
nisms responsible for the effects of chronic R. rosea ingestion
in healthy persons require further investigations.
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